Cargando…

Anthelmintics as Potential Anti-Cancer Drugs?

Detalles Bibliográficos
Autor principal: Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025903/
https://www.ncbi.nlm.nih.gov/pubmed/32056406
http://dx.doi.org/10.3346/jkms.2020.35.e75
_version_ 1783498581680848896
author Heo, Dae Seog
author_facet Heo, Dae Seog
author_sort Heo, Dae Seog
collection PubMed
description
format Online
Article
Text
id pubmed-7025903
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-70259032020-02-20 Anthelmintics as Potential Anti-Cancer Drugs? Heo, Dae Seog J Korean Med Sci Editorial The Korean Academy of Medical Sciences 2020-02-10 /pmc/articles/PMC7025903/ /pubmed/32056406 http://dx.doi.org/10.3346/jkms.2020.35.e75 Text en © 2020 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Heo, Dae Seog
Anthelmintics as Potential Anti-Cancer Drugs?
title Anthelmintics as Potential Anti-Cancer Drugs?
title_full Anthelmintics as Potential Anti-Cancer Drugs?
title_fullStr Anthelmintics as Potential Anti-Cancer Drugs?
title_full_unstemmed Anthelmintics as Potential Anti-Cancer Drugs?
title_short Anthelmintics as Potential Anti-Cancer Drugs?
title_sort anthelmintics as potential anti-cancer drugs?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025903/
https://www.ncbi.nlm.nih.gov/pubmed/32056406
http://dx.doi.org/10.3346/jkms.2020.35.e75
work_keys_str_mv AT heodaeseog anthelminticsaspotentialanticancerdrugs